Tempsens Instruments IPO Day 3: GMP Soars 105% as Demand Surges
The Tempsens Instruments IPO has attracted intense investor attention on the final day of bidding, with the grey market premium (GMP) climbing to around 105% and subscription demand remaining exceptionally strong. The ₹650 crore mainboard issue, which opened on August 20, is scheduled to close on August 24, 2026.
The reported GMP of about ₹315 against the upper issue price of ₹300 implies an indicative grey-market price of roughly ₹615. That represents a premium of approximately 105%. However, GMP is an unofficial market indicator and should not be interpreted as a guaranteed listing price or return.
The bigger question for investors is whether the enthusiasm surrounding the Tempsens Instruments IPO is justified by the company's underlying business and financial performance.
Tempsens Instruments IPO: Key Details
Tempsens Instruments is a thermal engineering and specialised cable manufacturer with products spanning temperature measurement, electrical heating solutions and specialised cables.
The IPO has a price band of ₹285–₹300 per share, with a lot size of 50 shares. At the upper price band, the minimum retail application is ₹15,000. The issue size is ₹650 crore, comprising a ₹95 crore fresh issue and ₹555 crore offer for sale (OFS).
The IPO is scheduled to list on both BSE and NSE, with August 28 currently indicated as the listing date by major IPO trackers.
The structure of the issue is worth noticing. About 85% of the total IPO value comes through the OFS, meaning most of the money raised from that portion goes to selling shareholders rather than directly into the company's balance sheet.
The fresh issue, however, provides funds for specific business requirements, including capital expenditure and debt repayment.
Subscription Demand Has Been Strong
Investor interest accelerated rapidly after the IPO opened.
By the end of Day 2, the issue had been subscribed around 21.7 times, according to available exchange-linked subscription data. Non-institutional investors were particularly aggressive, with their portion subscribed nearly 53 times, while the retail category was subscribed around 18.7 times and the QIB portion around 3.3 times.
Intraday subscription figures can change as new bids arrive on the final day. Reports on August 24 described demand moving toward the 38-times level as the issue entered its final hours.
This combination of strong subscription and a triple-digit GMP has created expectations of a potentially strong listing.
But there is an important distinction between IPO demand and long-term investment demand. Heavy subscription can partly reflect investors seeking listing gains, especially when the grey market is quoting a large premium.
Why Is the Tempsens IPO Attracting Investors?
The company operates in a specialised industrial segment rather than a highly commoditised manufacturing category.
Tempsens makes temperature-sensing products such as thermocouples, resistance temperature detectors, infrared pyrometers, thermal imaging products and fibre-optic temperature sensors. It also manufactures electrical heating systems and specialised cables.
Its products serve industries where accurate temperature measurement and control are important, including sectors such as metals, petrochemicals, power, pharmaceuticals and other industrial applications.
One of the company's differentiators is its position in specialised temperature-sensing products. According to IPO research, Tempsens was India's largest manufacturer of contact and non-contact temperature sensors by revenue in FY26, with an estimated market share of about 10.5% in that segment.
The company also manufactures fibre-optic temperature sensors domestically, a niche capability that can create entry barriers for competitors.
Financial Growth Supports the Bull Case
The strong IPO response is not based solely on GMP.
Tempsens has demonstrated growth in revenue and profitability over recent years. Its business has benefited from demand across industrial sectors and exports, while its specialised product portfolio supports relatively healthy margins compared with many traditional manufacturing businesses.
Industry research cited ahead of the IPO points to an EBITDA margin of roughly 25% and a relatively low debt-to-equity ratio of around 0.15 times in FY26.
The company's export business is another growth avenue. Around 29% of revenue was generated from exports, giving Tempsens exposure to international industrial demand.
For investors, this combination of niche products, industrial customers, export potential and profitability makes the business more interesting than a simple commodity-manufacturing IPO.
But Valuation Is the Key Concern
The market's enthusiasm has pushed attention toward valuation.
At ₹300 per share, Tempsens is being valued at a premium to several traditional engineering businesses. Some IPO research has highlighted a FY26 P/E valuation in the mid-30s, making execution important for investors entering at the upper price band.
A high valuation is not automatically a problem if earnings continue growing quickly.
But the margin for disappointment becomes smaller.
If industrial demand slows, export growth weakens or margins contract, the stock could face pressure because investors are already paying for a meaningful amount of future growth.
This is particularly important when the GMP is also extremely high. A strong grey-market premium can create expectations that are difficult for a newly listed company to meet.
Working Capital Needs Watching
Another issue investors should not overlook is working capital.
Research published ahead of the IPO noted that Tempsens' net working-capital days increased from approximately 152 days in FY24 to 210 days in FY26.
Working-capital days measure how much time a business effectively has money tied up in receivables and inventory relative to its sales.
For a manufacturing company, rising working-capital requirements can absorb cash even when accounting profits are increasing.
That does not necessarily undermine the business, but investors should monitor whether future revenue growth is accompanied by improving cash conversion.
The OFS Structure Also Deserves Attention
The ₹650 crore issue includes a ₹555 crore OFS.
That means the overwhelming majority of the public offering is a sale by existing shareholders rather than fresh capital being raised by the company.
For investors, an OFS is not inherently negative. Existing shareholders may sell for many legitimate reasons, including portfolio restructuring or partial profit realisation.
However, the limited fresh issue means investors should not assume that the entire ₹650 crore will be available for expansion.
The company is receiving only the proceeds from the ₹95 crore fresh issue, with the stated objectives including capital expenditure and repayment of borrowings.
GMP at 105%: Should Investors Trust It?
The 105% GMP is clearly the biggest headline surrounding the Tempsens IPO.
At the ₹300 upper price band, a ₹315 GMP would imply an unofficial price of around ₹615.
But investors should treat this calculation as a sentiment indicator, not a forecast.
Grey-market transactions are outside the formal stock-exchange mechanism, and the premium can move sharply before listing. The actual listing price depends on market conditions, demand and supply when trading begins.
There is also a psychological risk. When an IPO develops a very high GMP, investors can begin focusing almost entirely on the expected listing gain and overlook valuation and business risks.
That is precisely when discipline becomes more important.
What Investors Should Watch After Listing
For those tracking Tempsens Instruments beyond the IPO, several indicators will matter more than the first-day price.
Revenue growth: Can the company maintain its expansion across domestic and export markets?
Margins: Can its specialised product mix continue supporting healthy profitability?
Working capital: Can the company reduce the amount of cash tied up in receivables and inventory?
Debt: Does the planned repayment improve the balance sheet?
Exports: Can international business become a larger and sustainable growth driver?
Industrial demand: How resilient are orders from metals, petrochemicals, power and other cyclical industries?
These factors will ultimately determine whether the premium valuation is justified.
Tempsens Instruments IPO: Investor Takeaway
The Tempsens Instruments IPO has entered its final day with exceptional market enthusiasm. Subscription demand has surged, while the GMP has climbed to around 105%, creating expectations of a potentially strong listing.
The underlying company has several attractive qualities: a specialised industrial product portfolio, strong positioning in temperature-sensing solutions, export exposure and healthy profitability.
However, investors should balance those positives against the premium valuation, rising working-capital requirements and the fact that ₹555 crore of the ₹650 crore issue is an OFS.
For listing-focused investors, the current market sentiment is clearly strong, but the GMP remains unofficial and can change quickly. For long-term investors, the more important question is whether Tempsens can continue growing earnings while maintaining margins and improving cash efficiency.
The IPO has strong momentum, but the real test will begin after listing.
Follow the blog for more IPO reviews, subscription updates, GMP analysis and stock-market news.
This article is for informational and educational purposes only and should not be considered investment advice
Comments
Post a Comment